SCHEMBL784554

SCHEMBL784554

CN(C(=O)c1ccc2c(c1)[C@H](NC(=O)Cc1ccccc1)CC2)C1CCN(c2ccncc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.43
DRD2 P14416 3/20 0.43
HTR2A P28223 2/20 0.43
KCNH2 Q12809 2/20 0.43
CCR5 P51681 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MCL1 Q07820 1/20 0.41
ME3 Q16798 1/20 0.41
MCHR1 Q99705 3/20 0.40
CTSS P25774 1/20 0.40
SIGMAR1 Q99720 2/20 0.39
ABL1 P00519 2/20 0.39
RIN1 Q13671 2/20 0.39
TMEM97 Q5BJF2 1/20 0.39
TAOK1 Q7L7X3 1/20 0.38
TAOK3 Q9H2K8 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
RIPK1 Q13546 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785446 0.89 CTSS (0.52) HTR1ADRD2HTR2AKCNH2CCR5
SCHEMBL784128 0.89 P2RX7 (0.40) CCR5MCHR1CTSSSIGMAR1TAOK1
SCHEMBL786234 0.89 CCR5 (0.40) DRD2CCR5MCHR1CTSSJAK2
SCHEMBL785608 0.87 MCHR1 (0.39) DRD2CCR5MCHR1TAOK1TAOK3
SCHEMBL785458 0.87 MCHR1 (0.39) DRD2CCR5MCHR1CTSSTAOK1
SCHEMBL785736 0.87 CCR5 (0.39) DRD2CCR5MCHR1CTSSTAOK1
SCHEMBL784956 0.87 CCR5 (0.39) DRD2CCR5MCHR1CTSSTAOK1
SCHEMBL785328 0.87 MCHR1 (0.38) DRD2CCR5MCHR1CTSSTAOK1
SCHEMBL27902562 0.87 CA12 (0.40) HTR1ADRD2HTR2AKCNH2CCR5
SCHEMBL785875 0.85 MCHR1 (0.39) HTR1ADRD2HTR2AKCNH2CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US claimed
CN-103097354-A Substituted benzamide compounds GRUENENTHAL CHEMIE 2013-05-08 CN claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US claimed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
CN-103097354-A Substituted benzamide compounds GRUENENTHAL CHEMIE 2013-05-08 CN disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 HTR1A 94/4885DRD2 64/4885HTR2A 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.